Pharmaceutical Intermediates Market

The global pharmaceutical intermediates market size was estimated to be US$ 29.5 billion in 2021 and is expected to grow at a CAGR of 7.2% between 2023 to 2032.

The raw materials that are used in the production of bulk drugs are known as pharmaceutical intermediates. They are produced during the synthesis of active pharmaceutical ingredient (API) as a byproduct. In the pharmaceutical and cosmetic industries they are widely used. Usually they are produced out of coal tar or petroleum but nowadays they are also produced by organic synthesis.

Pharmaceutical ingredients are used to produce pesticides, pharmaceuticals, plasticizers, additives and resins. Due the increase in research and development activities globally the demand for pharmaceutical ingredients is rapidly expanding.

Furthermore with the evolution in production technology and expanding international chemical industry, the demand for pharmaceutical intermediates around the world is growing. As they as basically intermediate products of certain products they are produced on demand for bulk and custom productions.

Pharmaceutical Intermediates Market Dynamics

Rising Prevalence of Chronic Diseases and Infectious Diseases

The rising demand to treat chronic diseases increases the requirements of pharmaceutical intermediates. Additionally the demand for APIs in the coming years will also rise due to surging prevalence of infectious diseases which in turn will bolster the growth of the global pharmaceutical intermediate market.

New treatment applications in cardiovascular disorders

Pharmaceutical intermediates are currently being used for treating cardiac disorders such as cardiac arrhythmia. Medical research and development will discover new applications of these intermediates and generate more lucrative opportunities in this market globally.

Increase in public and private healthcare expenditure

Due to an increasing demand for new drugs for COVID-19 and chronic diseases, there is an increase in funding for medical research activities and the growth of the market is certain. The growing awareness among the doctors and patients regarding chronic diseases and increase in public and private healthcare expenditure has further bolstered the market growth.

Pharmaceutical Intermediates Market Challenges

Complexities in Manufacturing

Manufacturing pharmaceutical intermediates is a costly process that requires significant investments, clinical trial expertise, quality systems, scientific standards and technical capabilities. Pharmaceutical intermediates manufacturers are required to invest in clinical trials and post-approval safety monitoring programs that are similar to that of original innovator companies.

Strict Government Regulations

Government regulators around the world have imposed various stringent regulations and standards pertaining to new pharmaceutical intermediate products which are expected to restrain market growth.

Side effects associated with intermediates

Many intermediates previously introduced have shown multiple adverse side effects and therefore have been not approved by the regulators. Such setbacks for the pharmaceutical intermediate manufacturers will further challenge the growth of this market globally.

Major companies profiled in the global pharmaceutical intermediates market are BASF SE, Lonza Group, Evonik Industries AG, Cambrex Corporation, DSM, Aceto, , Albemarle, Corporation, Vertellus, Chemcon Speciality Chemicals Ltd., Chiracon GmbH, Life Sciences Private Limited and others.

Pharmaceutical Intermediates Market Segmentation

By Product:

• Bulk Drug Intermediate
  • Chiral Intermediate
  • Achiral Intermediate
• Custom Intermediate
• Chemical Intermediate

By Application:

• Analgesics
• Anti-inflammatory Drug
• Cardiovascular Drugs
• Anti-diabetic Drugs
• Antimicrobial Drugs
• Anti-cancer Drugs
• Others

By End User:

• Pharmaceutical & Biotechnology Companies
• Reasearch Companies
• CROs & CMOs

By Geography

• North America
  • United States
  • Canada
  • Rest of North America
• Europe
  • Germany
  • United Kingdom
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • India
  • China
  • Australia
  • Rest of Asia Pacific
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • South Africa
  • Rest of the Middle East & Africa
• South America
  • Brazil
  • Rest of South America